These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 4932306)

  • 41. Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006).
    Sire JM; Macondo EA; Perrier-Gros-Claude JD; Siby T; Bahsoun I; Seck A; Garin B
    Jpn J Infect Dis; 2008 Jul; 61(4):307-9. PubMed ID: 18653976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IN VITRO SUSCEPTIBILITY OF SHIGELLAE TO SODIUM SULFADIAZINE AND TO EIGHT ANTIBIOTICS.
    HALTALIN KC; NELSON JD
    JAMA; 1965 Aug; 193():705-10. PubMed ID: 14328468
    [No Abstract]   [Full Text] [Related]  

  • 43. An epidemic-associated episome?
    Gangarosa EJ; Bennett JV; Wyatt C; Pierce PE; Olarte J; Hernandes PM; Vázquez V; Bessudo D
    J Infect Dis; 1972 Aug; 126(2):215-8. PubMed ID: 4559853
    [No Abstract]   [Full Text] [Related]  

  • 44. R-factors and behavior of their determinants in strains of enterobacteria of different origins.
    Kheinaru AL; Tallmeister ET
    Sov Genet; 1973 Jul; 7(1):94-102. PubMed ID: 4612731
    [No Abstract]   [Full Text] [Related]  

  • 45. Ampicillin inthe treatment of shigellosis.
    Patton LH; Crawford SE; Inclan AP
    South Med J; 1968 May; 61(5):501-4. PubMed ID: 4869885
    [No Abstract]   [Full Text] [Related]  

  • 46. Epidemic Shiga bacillus dysentery in Central Africa.
    Ebright JR; Moore EC; Sanborn WR; Schaberg D; Kyle J; Ishida K
    Am J Trop Med Hyg; 1984 Nov; 33(6):1192-7. PubMed ID: 6391226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic effect of hetacillin in dysentery patients and carriers].
    Yamagami S; Akao M
    Jpn J Antibiot; 1968 Jun; 21(3):115-7. PubMed ID: 4881249
    [No Abstract]   [Full Text] [Related]  

  • 48. Transferable drug resistance in enterobacteria isolated from urban infants.
    Moorhouse EC
    Br Med J; 1969 May; 2(5654):405-7. PubMed ID: 4889237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic properties of R factors associated with epidemic strains of Shigella dysenteriae type I from Central America and Salmonella typhi from Mexico.
    Thorne GM; Farrar WE
    J Infect Dis; 1973 Jul; 128(1):132-6. PubMed ID: 4577973
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of bacillary dysentery with lincomycin].
    Totani T; Amano F
    Jpn J Antibiot; 1968 Dec; 21(6):350-3. PubMed ID: 4887886
    [No Abstract]   [Full Text] [Related]  

  • 51. [ON SOME CURRENT PROBLEMS IN MICROBIOLOGICAL DIAGNOSIS, EPIDEMIOLOGY, THERAPY AND PREVENTION OF BACILLARY DYSENTERY. V. STATE OF SHIGELLA SENSITIVITY TO ANTIBIOTICS].
    ALDOVA E; JELINEK J
    Cesk Epidemiol Mikrobiol Imunol; 1964 Mar; 13():96-101. PubMed ID: 14142629
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibiotic guidelines for hand infections.
    Eaton RG; Butsch DP
    Surg Gynecol Obstet; 1970 Jan; 130(1):119-22. PubMed ID: 4312012
    [No Abstract]   [Full Text] [Related]  

  • 53. [Transmissible multiple drug resistance of Enterobacteria].
    Leplìa ES
    Antibiotiki; 1971 Mar; 16(3):270-3. PubMed ID: 4934286
    [No Abstract]   [Full Text] [Related]  

  • 54. R factors in strains of Salmonella typhi and Shigella dysenteriae 1 isolated during epidemics in Mexico: classification by compatibility.
    Datta N; Olarte J
    Antimicrob Agents Chemother; 1974 Mar; 5(3):310-7. PubMed ID: 4599123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Characteristics of drug resistance of dysentry bacteria isolated in Minsk].
    Lobanok TE; Fomichev IuK
    Antibiotiki; 1970 Jan; 15(1):85-8. PubMed ID: 4909954
    [No Abstract]   [Full Text] [Related]  

  • 56. Antimicrobial drugs for treatment of infections caused by aerobic gram-negative bacilli.
    Boxerbaum B
    Med Clin North Am; 1974 May; 58(3):519-32. PubMed ID: 4362721
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies of dysenteric infection in a closed children's community before and after anti-dysentery vaccination. II. Data on the response to antibiotics and chemotherapy].
    Dragomir I; Raicu MD; Cadariu M; Iancu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(2):103-6. PubMed ID: 6999586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of Shiga toxin 1 genes within Shigella dysenteriae type 4 isolates from travelers returning from the Island of Hispañola.
    Gupta SK; Strockbine N; Omondi M; Hise K; Fair MA; Mintz E
    Am J Trop Med Hyg; 2007 Jun; 76(6):1163-5. PubMed ID: 17556630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shigellosis (antibiotic resistance and transfer of R-factor).
    Gaikwad S; Deodhar LP
    J Postgrad Med; 1985 Jan; 31(1):24-7. PubMed ID: 3900357
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antibiotic resistance of Shigella, isolated during 1966-1967, in some populated areas of Central Povolozh'e and their comparative characteristics at a 10 year interval].
    Blokhov VP; Raĭgorodskaia AG
    Antibiotiki; 1969 Dec; 14(12):1110-1. PubMed ID: 4905939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.